04 Nov 2008 YM Biosciences Reports Data From Exploratory Clinical Trials of Nimotuzumab in Brain Metastases and High-Grade Glioma Presentes at 2008 EORTC-NCI-AACR Annual Meeting
04 Nov 2008 Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
03 Nov 2008 Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)
03 Nov 2008 CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
03 Nov 2008 Genentech Submits Application to U.S. Food and Drug Administration for Avastin in the Most Aggressive Form of Brain Cancer
01 Nov 2008 GlobeImmune Hepatitis C Therapeutic Vaccine, GI-5005, Doubles Viral Clearance and Increases RVR Rates in Phase 2 Clinical Trial
30 Oct 2008 New Cimzia(R) study shows rapid reduction of symptoms and progression of rheumatoid arthritis
30 Oct 2008 ERBITUX(R) Supplemental Biologics License Application for First-Line Recurrent or Metastatic Head and Neck Cancer Accepted for Priority Review by U.S. Food and Drug Administration
30 Oct 2008 Biogen Idec Elects to Participate with Genentech in the Development and Commercialization of a Next Generation Anti-CD20 Molecule
29 Oct 2008 Phase 2a Data for MEDI-528 Presented at CHEST 2008
29 Oct 2008 Merck KGaA and Lpath Form Alliance for ASONEP
28 Oct 2008 Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
28 Oct 2008 Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
28 Oct 2008 BioWa Announces License of Biowa's Potelligent(R) Technology to KaloBios Pharmaceuticals
28 Oct 2008 Seattle Genetics Presents on SGN-70 at American College of Rheumatology Meeting
28 Oct 2008 Affitech Acquires Pharmexa's Diabody Technology
27 Oct 2008 One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study
27 Oct 2008 New data shows ACTEMRA inhibits progression of joint destruction and improves physical function of patients with Rheumatoid Arthritis
27 Oct 2008 Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis
27 Oct 2008 Progenics Reports Positive Interim Phase 2 Results for Two Dosage Forms of Novel HIV Therapy PRO 140
27 Oct 2008 CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
27 Oct 2008 Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
27 Oct 2008 WEHI Spin-Out MuriGen Restructures G-CSF Antagonist Program With CSL
27 Oct 2008 New Study Shows ENBREL(R) (etanercept) Is More Effective than a DMARD in the Treatment of Symptoms of Ankylosing Spondylitis Patients
27 Oct 2008 ACZ885 Phase III data show rapid, sustained clinical remission in children and adults suffering from a group of rare, potentially life-threatening autoinflammatory diseases

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing